Effect of Post-Dilatation Following Primary PCIWith Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stent Implantation An Angiographic and Optical Coherence Tomography TROFI II Substudy

被引:17
|
作者
Yamaji, Kyohei [1 ]
Brugaletta, Salvatore [2 ]
Sabate, Manel [2 ]
Iniguez, Andres [3 ]
Jensen, Lisette Okkels [4 ]
Cequier, Angel [5 ]
Hofma, Sjoerd H. [6 ]
Christiansen, Evald Hoj [7 ]
Suttorp, Maarten [8 ]
van Es, Gerrit Anne [9 ,10 ]
Sotomi, Yohei [11 ]
Onuma, Yoshinobu [9 ,12 ]
Serruys, Patrick W. [13 ]
Windecker, Stephan [1 ]
Raber, Lorenz [1 ]
机构
[1] Bern Univ Hosp, Dept Cardiol, Bern, Switzerland
[2] Univ Barcelona, Thorax Inst, Univ Hosp Clin, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain
[3] Hosp Alvaro Cunqueiro, Vigo, Spain
[4] Odense Univ Hosp, Odense, Denmark
[5] Bellvitge Univ Hosp, Barcelona, Spain
[6] Med Ctr Leeuwarden, Leeuwarden, Netherlands
[7] Aarhus Univ Hosp, Skejby, Denmark
[8] St Antonius Hosp, Nieuwegein, Netherlands
[9] Cardialysis BV, Rotterdam, Netherlands
[10] European Cardiovasc Res Inst, Rotterdam, Netherlands
[11] Acad Med Ctr, Heart Ctr, Amsterdam, Netherlands
[12] Erasmus MC, Thorax Ctr, Rotterdam, Netherlands
[13] Imperial Coll, Int Ctr Circulatory Hlth, NHLI, London, England
关键词
bioresorbable vascular scaffold; optical coherence tomography; percutaneous coronary intervention; ST-segment elevation myocardial infarction; PERCUTANEOUS CORONARY INTERVENTION; VASCULAR SCAFFOLDS; INTRAVASCULAR ULTRASOUND; ARTERY-DISEASE; MYOCARDIAL-INFARCTION; PROGNOSTIC VALUE; THROMBOSIS; OUTCOMES; MECHANISMS; IMPACT;
D O I
10.1016/j.jcin.2017.07.035
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES This study sought to investigate the effect of post-dilatation on angiographic and intracoronary imaging parameters in the setting of primary percutaneous coronary intervention comparing the everolimus-eluting bioresorbable scaffold (BRS) with the everolimus-eluting metallic stent (EES). BACKGROUND Routine post-dilatation of BRS has been suggested to improve post-procedural angiographic and subsequent device-related clinical outcomes. METHODS In the ABSORB STEMI TROFI II trial, 191 patients with ST-segment elevation myocardial infarction were randomly assigned to treatment with BRS (n = 95) or EES (n = 96). Minimal lumen area and healing score as assessed by optical coherence tomography at 6 months were compared between BRS-and EES-treated patients stratified according to post-dilatation status. RESULTS Primary percutaneous coronary intervention with post-dilatation was performed in 48 (50.5%) BRS-and 25 (25.5%) EES-treated lesions. There were no differences in baseline characteristics and post-procedural minimal lumen diameter between groups. In the BRS group, lesions with post-dilatation were associated with a trend toward a smaller minimal lumen area at 6 months (5.07 +/- 1.68 mm(2) vs. 5.72 +/- 1.77 mm(2); p = 0.09) and significantly larger angiographic late lumen loss (0.28 +/- 0.34mmvs. 0.12 +/- 0.25 mm; p = 0.02), whereas no difference was observed in the EES arm (5.46 +/- 2.18 mm(2) vs. 5.55 +/- 1.77 mm(2); p = 0.85). The neointimal healing score was low and comparable between groups with and without post-dilation (BRS: 1.55 +/- 2.61 vs. 1.92 +/- 2.17; p = 0.48; EES: 2.50 +/- 3.33 vs. 2.90 +/- 4.80; p = 0.72). CONCLUSIONS In the setting of selected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with BRS or EES, post-dilatation did not translate into larger lumen area or improved arterial healing at follow-up. (C) 2017 by the American College of Cardiology Foundation.
引用
收藏
页码:1867 / 1877
页数:11
相关论文
共 50 条
  • [1] Mechanical properties of the everolimus-eluting bioresorbable vascular scaffold compared to the metallic everolimus-eluting stent
    Dalos, Daniel
    Gangl, Clemens
    Roth, Christian
    Krenn, Lisa
    Scherzer, Sabine
    Vertesich, Markus
    Lang, Irene
    Maurer, Gerald
    Neunteufl, Thomas
    Berger, Rudolf
    Delle-Karth, Georg
    BMC CARDIOVASCULAR DISORDERS, 2016, 16
  • [2] Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stents RESPONSE
    Zhang, Xin-Lin
    Xu, Biao
    ANNALS OF INTERNAL MEDICINE, 2016, 165 (11) : 829 - 829
  • [3] Comparative Efficacy and Safety of Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stents
    Zhang, Xin-Lin
    Zhu, Li
    Wei, Zhong-Hai
    Zhu, Qing-Qing
    Qiao, Jian-Zhong
    Dai, Qing
    Huang, Wei
    Li, Xiao-Hong
    Xie, Jun
    Kang, Li-Na
    Wang, Lian
    Xu, Biao
    ANNALS OF INTERNAL MEDICINE, 2016, 164 (11) : 752 - +
  • [4] Mechanical properties of the everolimus-eluting bioresorbable vascular scaffold compared to the metallic everolimus-eluting stent
    Daniel Dalos
    Clemens Gangl
    Christian Roth
    Lisa Krenn
    Sabine Scherzer
    Markus Vertesich
    Irene Lang
    Gerald Maurer
    Thomas Neunteufl
    Rudolf Berger
    Georg Delle-Karth
    BMC Cardiovascular Disorders, 16
  • [5] Comparison of the everolimus-eluting bioresorbable vascular scaffold versus the everolimus-eluting metallic stent in real-world patients with ST-segment elevation myocardial infarction
    Desperak, Piotr
    Hawranek, Michal
    Chodor, Piotr A.
    Swiatkowski, Andrzej
    Kowalczyk, Jacek
    Lekston, Andrzej
    Gasior, Mariusz
    POSTEPY W KARDIOLOGII INTERWENCYJNEJ, 2020, 16 (01): : 49 - 57
  • [6] Fate of post-procedural malapposition of everolimus-eluting polymeric bioresorbable scaffold and everolimus-eluting cobalt chromium metallic stent in human coronary arteries: sequential assessment with optical coherence tomography in ABSORB Japan trial
    Sotomi, Yohei
    Onuma, Yoshinobu
    Dijkstra, Jouke
    Miyazaki, Yosuke
    Kozuma, Ken
    Tanabe, Kengo
    Popma, Jeffrey J.
    de Winter, Robbert J.
    Serruys, Patrick W.
    Kimura, Takeshi
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2018, 19 (01) : 59 - 66
  • [7] Vascular response to everolimus- and biolimus-eluting coronary stents versus everolimus-eluting bioresorbable scaffolds - an optical coherence tomography substudy of the EVERBIO II trial
    Kallinikou, Zacharenia
    Arroyo, Diego
    Togni, Mario
    Lehmann, Sonja
    Corpataux, Noe
    Cook, Malica
    Mueller, Olivier
    Baeriswyl, Gerard
    Stauffer, Jean-Christophe
    Goy, Jean-Jacques
    Puricel, Serban
    Cook, Stephane
    SWISS MEDICAL WEEKLY, 2016, 146 : w14274
  • [8] Comparison of neointimal coverage between everolimus-eluting stents and sirolimus-eluting stents: an optical coherence tomography substudy of the RESET (Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting stent Trial)
    Kubo, Takashi
    Akasaka, Takashi
    Kozuma, Ken
    Kimura, Kazuo
    Kawamura, Masaki
    Sumiyoshi, Tetsuya
    Ino, Yasushi
    Morino, Yoshihiro
    Tanabe, Kengo
    Kadota, Kazushige
    Kimura, Takeshi
    EUROINTERVENTION, 2015, 11 (05) : 564 - 571
  • [9] The Impact of Post-Procedural Asymmetry, Expansion, and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II Trial
    Suwannasom, Pannipa
    Sotomi, Yohei
    Ishibashi, Yuki
    Cavalcante, Rafael
    Albuquerque, Felipe N.
    Macaya, Carlos
    Ormiston, John A.
    Hill, Jonathan
    Lang, Irene M.
    Egred, Mohaned
    Fajadet, Jean
    Lesiak, Maciej
    Tijssen, Jan G.
    Wykrzykowska, Joanna J.
    de Winter, Robbert J.
    Chevalier, Bernard
    Serruys, Patrick W.
    Onuma, Yoshinobu
    JACC-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (12) : 1231 - 1242
  • [10] Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial
    Onuma, Yoshinobu
    Sotomi, Yohei
    Shiomi, Hiroki
    Ozaki, Yukio
    Namiki, Atsuro
    Yasuda, Satoshi
    Ueno, Takafumi
    Ando, Kenji
    Furuya, Jungo
    Igarashi, Keiichi
    Kozuma, Ken
    Tanabe, Kengo
    Kusano, Hajime
    Rapoza, Richard
    Popma, Jeffrey J.
    Stone, Gregg W.
    Simonton, Charles
    Serruys, Patrick W.
    Kimura, Takeshi
    EUROINTERVENTION, 2016, 12 (09) : 1090 - 1101